York P-C Pei, MSc, MD, FRCPC

Dr. Pei is a Professor of Medicine at the University of Toronto. He is also a staff nephrologist at the Toronto General Hospital, University Health Network, where he directs the Center for Innovative Management for Polycystic Kidney Disease. He received research training in both Clinical Epidemiology and Human Molecular Genetics. His research program focuses on genetic, genomic, and translational research of hereditary kidney diseases with a major focus on autosomal dominant polycystic kidney disease and is supported by grants from the Kidney Foundation of Canada, Physicians Incorporated Foundation, Polycystic Kidney Disease Foundation (USA), and the Canadian Institutes of Health Research.

He has published more than 100 peer-reviewed papers and has served on the Editorial Board for the Journal of the American Society of Nephrology and Grant Review Panels for the Kidney Foundation of Canada, Canadian Institutes of Health Research, PKD foundation (USA), and National Institutes of Health, USA. He was a co-recipient of the 2019 Lillian J. Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease.

The major theme of his research program is to identify genetic factors involved in the initiation or progression of common kidney diseases, as potential targets for developing novel diagnostic tests and therapies. His research focuses on genetic, genomic and translational research of several hereditary kidney disorders including autosomal dominant polycystic kidney disease, IgA nephropathy and idiopathic nephrotic syndrome, and is supported by grants from the Kidney Foundation of Canada, Physicians Incorporated Foundation, and Canadian Institutes of Health Research.
EBioMedicine. 2019 Aug 28;:
Leonhard WN, Song X, Kanhai AA, Iliuta IA, Bozovic A, Steinberg GR, Peters DJM, Pei Y
Sci Rep. 2019 Jul 29;9(1):10996
Shi B, Akbari P, Pourafkari M, Iliuta IA, Guiard E, Quist CF, Song X, Hillier D, Khalili K, Pei Y
Kidney Int Rep. 2019 Jul;4(7):995-1003
Lanktree MB, Guiard E, Li W, Akbari P, Haghighi A, Iliuta IA, Shi B, Chen C, He N, Song X, Margetts PJ, Ingram AJ, Khalili K, Paterson AD, Pei Y
Chin Med J (Engl). 2019 Jul 20;132(14):1660-1665
Wang C, Pei YY, Ma YH, Ma XL, Liu ZW, Zhu JH, Li CS
Anticancer Drugs. 2019 Jan 16;:
Li S, Wu X, Chen P, Pei Y, Zheng K, Wang W, Qiu E, Zhang X
Nephrology (Carlton). 2019 Jan 20;:
Cho Y, Sautenet B, Gutman T, Rangan G, Craig JC, Ong AC, Chapman A, Ahn C, Coolican H, Kao JT, Gansevoort R, Perrone RD, Harris T, Torres V, Pei Y, Kerr PG, Ryan J, Johnson DW, Viecelli AK, Geneste C, Kim H, Kim Y, Oh YK, Teixeira-Pinto A, Logeman C,...
Clin J Am Soc Nephrol. 2019 Jan 15;:
Yao T, Udwan K, John R, Rana A, Haghighi A, Xu L, Hack S, Reich HN, Hladunewich MA, Cattran DC, Paterson AD, Pei Y, Barua M
Biomed Res Int. 2018;2018:5484731
Saijun Z, Xin L, Jie W, Shumin X, Shuaihui L, Pei Y
Nephrol Dial Transplant. 2018 Aug 27;:
Lanktree MB, Iliuta IA, Haghighi A, Song X, Pei Y



Professor of Medicine, University of Toronto
Director, Hereditary Kidney Disease Clinic, Unviersity Health Network
Staff Nephrologist at the Toronto General Hospital